Establishment of a Highly Sensitive Assay for Detection of Hepatitis E Virus-Specific Immunoglobulins

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2019 Nov 8

PMID 31694975

Citations 2

Authors

Katrin Bohm

Julia Strompl

Andi Krumbholz

Roland Zell

Gerard Krause

Claudia Sievers

Affiliations

Soon will be listed here.

Abstract

Hepatitis E, a liver disease caused by infection with the hepatitis E virus (HEV), is a worldwide emerging disease. The diagnosis is based on the detection of viral RNA and of HEV-specific immunoglobulins (Ig). For the latter, various assays are commercially available but still lack harmonization. In this study, a Luminex-based multiplex serological assay was established that measures the presence of total IgG, IgA, and IgM antibodies, targeting a short peptide derived from the viral E2 protein. For the validation, 160 serum samples with a known HEV serostatus were used to determine the assay cutoff and accuracy. Thereby, HEV IgG- and RNA-positive sera were identified with a sensitivity of 100% and a specificity of 98% (95% confidence interval [CI], 94% to 100%). Application of the assay by retesting 514 serum samples previously characterized with different HEV-IgG or total antibody tests revealed a high level of agreement between the assays (Cohen's kappa, 0.58 to 0.99). The established method is highly sensitive and specific and can be easily implemented in a multiplex format to facilitate rapid differential diagnostics with a few microliters of sample input.

Citing Articles

Seroprevalence of Hepatitis E virus in children and adolescents living in urban Bogotá: An explorative cross-sectional study.

Fernandez Villalobos N, Kessel B, Torres Paez J, Strompl J, Kerrinnes T, de la Hoz Restrepo F Front Public Health. 2023; 11:981172.

PMID: 36844812 PMC: 9943700. DOI: 10.3389/fpubh.2023.981172.

Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts' meeting on serum biomarkers.

Wiens K, Jauregui B, Arnold B, Banke K, Wade D, Hayford K PLoS Negl Trop Dis. 2022; 16(10):e0010657.

PMID: 36201428 PMC: 9536637. DOI: 10.1371/journal.pntd.0010657.

References

Khudyakov Y, Khudyakova N, Fields H, Jue D, Starling C, Favorov M . Epitope mapping in proteins of hepatitis E virus. Virology. 1993; 194(1):89-96. DOI: 10.1006/viro.1993.1238. View

Dondog B, Schnitzler P, Michael K, Clifford G, Franceschi S, Pawlita M . Hepatitis C Virus Seroprevalence in Mongolian Women Assessed by a Novel Multiplex Antibody Detection Assay. Cancer Epidemiol Biomarkers Prev. 2015; 24(9):1360-5. DOI: 10.1158/1055-9965.EPI-15-0351. View

Krumbholz A, Joel S, Dremsek P, Neubert A, Johne R, Durrwald R . Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany. Med Microbiol Immunol. 2014; 203(4):273-82. DOI: 10.1007/s00430-014-0336-3. View

Zhou Y, Purcell R, Emerson S . A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus. Vaccine. 2005; 23(24):3157-65. DOI: 10.1016/j.vaccine.2004.12.020. View

Tam A, Smith M, Guerra M, Huang C, Bradley D, FRY K . Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology. 1991; 185(1):120-31. PMC: 7130833. DOI: 10.1016/0042-6822(91)90760-9. View

Wedemeyer H, Pischke S, Manns M . Pathogenesis and treatment of hepatitis e virus infection. Gastroenterology. 2012; 142(6):1388-1397.e1. DOI: 10.1053/j.gastro.2012.02.014. View

King N, Hewitt J, Perchec-Merien A . Hiding in Plain Sight? It's Time to Investigate Other Possible Transmission Routes for Hepatitis E Virus (HEV) in Developed Countries. Food Environ Virol. 2018; 10(3):225-252. DOI: 10.1007/s12560-018-9342-8. View

Meng J, Dai X, Chang J, Lopareva E, Pillot J, Fields H . Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology. 2001; 288(2):203-11. DOI: 10.1006/viro.2001.1093. View

Smith D, Simmonds P, Members Of The International Committee On The Taxonomy Of Viruses Study Group , Jameel S, Emerson S, Harrison T . Consensus proposals for classification of the family Hepeviridae. J Gen Virol. 2014; 95(Pt 10):2223-2232. PMC: 4165930. DOI: 10.1099/vir.0.068429-0. View

10.

Wang H, Zhang W, Gu H, Chen W, Zeng M, Ji C . Identification and characterization of two linear epitope motifs in hepatitis E virus ORF2 protein. PLoS One. 2017; 12(9):e0184947. PMC: 5619941. DOI: 10.1371/journal.pone.0184947. View

11.

Zhou Y, Zhao C, Tian Y, Xu N, Wang Y . Characteristics and Functions of HEV Proteins. Adv Exp Med Biol. 2016; 948:17-38. DOI: 10.1007/978-94-024-0942-0_2. View

12.

Zhu F, Zhang J, Zhang X, Zhou C, Wang Z, Huang S . Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010; 376(9744):895-902. DOI: 10.1016/S0140-6736(10)61030-6. View

13.

Khuroo M, Khuroo M, Khuroo N . Hepatitis E: Discovery, global impact, control and cure. World J Gastroenterol. 2016; 22(31):7030-45. PMC: 4988308. DOI: 10.3748/wjg.v22.i31.7030. View

14.

Shinde N, Patil T, Deshpande A, Gulhane R, Patil M, Bansod Y . Clinical profile, maternal and fetal outcomes of acute hepatitis e in pregnancy. Ann Med Health Sci Res. 2014; 4(Suppl 2):S133-9. PMC: 4145510. DOI: 10.4103/2141-9248.138033. View

15.

Batts W, Yun S, Hedrick R, Winton J . A novel member of the family Hepeviridae from cutthroat trout (Oncorhynchus clarkii). Virus Res. 2011; 158(1-2):116-23. DOI: 10.1016/j.virusres.2011.03.019. View

16.

Pas S, Streefkerk R, Pronk M, de Man R, Beersma M, Osterhaus A . Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol. 2013; 58(4):629-34. DOI: 10.1016/j.jcv.2013.10.010. View

17.

Khuroo M . Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med. 1980; 68(6):818-24. DOI: 10.1016/0002-9343(80)90200-4. View

18.

Kmush B, Labrique A, Dalton H, Ahmed Z, Ticehurst J, Heaney C . Two Generations of "Gold Standards": The Impact of a Decade in Hepatitis E Virus Testing Innovation on Population Seroprevalence. Am J Trop Med Hyg. 2015; 93(4):714-717. PMC: 4596587. DOI: 10.4269/ajtmh.15-0159. View

19.

Kamar N, Pischke S . Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment. Cold Spring Harb Perspect Med. 2018; 9(7). PMC: 6601456. DOI: 10.1101/cshperspect.a031872. View

20.

Waterboer T, Sehr P, Michael K, Franceschi S, Nieland J, Joos T . Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem. 2005; 51(10):1845-53. DOI: 10.1373/clinchem.2005.052381. View